| NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome S Chitturi, S Abeygunasekera, GC Farrell, J Holmes-Walker, JM Hui, ... Hepatology 35 (2), 373-379, 2002 | 1560 | 2002 |
| Etiopathogenesis of nonalcoholic steatohepatitis S Chitturi, GC Farrell Seminars in liver disease 21 (01), 027-042, 2001 | 1056 | 2001 |
| Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary GC Farrell, S Chitturi, GKK Lau, JD Sollano, ... Journal of gastroenterology and hepatology 22 (6), 775-777, 2007 | 602 | 2007 |
| Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? S Chitturi, G Farrell, L Frost, A Kriketos, R Lin, C Liddle, D Samarasinghe, ... Hepatology 36 (2), 403-409, 2002 | 581 | 2002 |
| NAFLD in Asia—as common and important as in the West GC Farrell, VWS Wong, S Chitturi Nature reviews Gastroenterology & hepatology 10 (5), 307-318, 2013 | 561 | 2013 |
| Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C JM Hui, JG Kench, S Chitturi, A Sud, GC Farrell, K Byth, P Hall, M Khan, ... Hepatology 38 (2), 420-427, 2003 | 546 | 2003 |
| Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment VWS Wong, WK Chan, S Chitturi, Y Chawla, YY Dan, A Duseja, J Fan, ... Journal of gastroenterology and hepatology 33 (1), 70-85, 2018 | 534 | 2018 |
| NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications GC Farrell, D Van Rooyen, L Gan, S Chitturi Gut and liver 6 (2), 149, 2012 | 521 | 2012 |
| Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines S Chitturi, GC Farrell, E Hashimoto, T Saibara, GKK Lau, JD Sollano, ... Journal of gastroenterology and hepatology 22 (6), 778-787, 2007 | 424 | 2007 |
| What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific? JG Fan, T Saibara, S Chitturi, BI Kim, JJY Sung, A Chutaputti, ... Journal of gastroenterology and hepatology 22 (6), 794-800, 2007 | 414 | 2007 |
| Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs S Chitturi, J George Seminars in liver disease 22 (02), 169-184, 2002 | 326 | 2002 |
| HFE mutations, hepatic iron, and fibrosis: ethnic‐specific association of NASH with C282Y but not with fibrotic severity S Chitturi, M Weltman, GC Farrell, D McDonald, C Liddle, ... Hepatology 36 (1), 142-149, 2002 | 289 | 2002 |
| Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region F GC J Gastroenterol Hepatol 22, 775-777, 2007 | 269 | 2007 |
| A fresh look at NASH pathogenesis. Part 1: the metabolic movers CZ Larter, S Chitturi, D Heydet, GC Farrell Journal of gastroenterology and hepatology 25 (4), 672-690, 2010 | 266 | 2010 |
| The Asia–Pacific Working Party on non‐alcoholic fatty liver disease guidelines 2017—part 2: management and special groups S Chitturi, VWS Wong, WK Chan, GLH Wong, SKH Wong, J Sollano, ... Journal of gastroenterology and hepatology 33 (1), 86-98, 2018 | 215 | 2018 |
| Herbal hepatotoxicity: an expanding but poorly defined problem S Chitturi, GC Farrell Journal of gastroenterology and hepatology 15 (10), 1093-1099, 2000 | 213 | 2000 |
| Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground S Chitturi, VWS Wong, G Farrell Journal of gastroenterology and hepatology 26, 163-172, 2011 | 210 | 2011 |
| Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? S Chitturi, GC Farrell, J George Journal of gastroenterology and hepatology 19 (4), 368-374, 2004 | 206 | 2004 |
| Pathogenesis and novel treatment options for non-alcoholic steatohepatitis VWS Wong, S Chitturi, GLH Wong, J Yu, HLY Chan, GC Farrell The Lancet Gastroenterology & Hepatology 1 (1), 56-67, 2016 | 201 | 2016 |
| Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease GC Farrell, F Haczeyni, S Chitturi Obesity, Fatty Liver and Liver Cancer, 19-44, 2018 | 181 | 2018 |
